Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRED: Comparison Of Two Triple Hypoglycemic Regimens In Newly Diagnosed Type 2 Diabetes
NCT07374328Phase 2Recruiting
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Start
- Jun 2025
- Primary completion
- May 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of semaglutide in type 2 diabetes mellitus (T2DM), sponsored by Second Affiliated Hospital of Guangzhou Medical University. Started Jun 2025; status: recruiting.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07374328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07374328.